PIK3CA in HER2+ BC and pCR Trial
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: GENETIC: PIK3CA analysis
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS